Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to evaluate the safety and preliminary efficacy of different
doses and several exposure times of intravitreal microplasmin in the setting of pars plana
vitrectomy for vitreomacular traction maculopathy.